Australian-listed Singapore-based diagnostics group Rockeby biomed Ltd (ASX:RBY) is pleased to announce that it has received European Over-The-Counter (OTC) approval 'CE OTC Mark' for the Company's flagship product CanDia5 for home or self testing in Europe.
